Cabometyx 20 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FFBS5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,949
Award facts
- Contract value 100% obligated
- $33,949.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $33,949.18 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Cabometyx 20 mg tablets (30-count units). The award, issued on December 23, 2025, with an ultimate completion date of December 24, 2025, carries no set-aside designation, indicating the vendor competed in the open market. This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical sourcing for Department of Defense healthcare operations globally.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with substantial recent contracting activity spanning oncology treatments, biologics, vaccines, and specialty pharmaceuticals. The company's single-award IDC under PPV-G GEN V, valued at $499,999,999 through December 31, 2036, positions it as a regional prime vendor contractor with authorization to deliver firm fixed-price orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to military healthcare facilities worldwide. The Cabometyx delivery represents one of numerous orders executed by the vendor to fulfill recurring medical supply requirements across the Department of Defense's healthcare system.
Quick answers
Who was awarded contract SPE2DR26FFBS5?
SPE2DR26FFBS5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26FFBS5 worth?
The government has obligated $33,949 on SPE2DR26FFBS5.
Is contract SPE2DR26FFBS5 an order under another contract?
Yes. SPE2DR26FFBS5 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBS5 competed?
The extent of competition for SPE2DR26FFBS5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award